Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057768 · ClinicalTrials.gov registry record · NA
Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles
A NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic, sponsored by Venus Concept.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04057768: Completed NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic, sponsored by Venus Concept.
NCT04057768 is a NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic that has completed, run by Venus Concept. The registered enrollment target is 10 participants, below the 120-participant average among 25 other Wrinkle trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04057768, a NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic, has completed, sponsored by Venus Concept.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.
Primary Outcome
Evaluate the efficacy of overall facial wrinkles improvement assessed live by the Investigator and a subject assessment of facial appearance including the Fitzpatrick Wrinkle and Elastosis Scale (FWES). The FWES is a 9 point scale. Three independent evaluators evaluated before and after photographs and graded them for change. Possible responses were: a score of 1 - 3 (Mild) indicates fine texture changes with subtly accentuated skin lines, a score of 4 - 6 (Moderate) indicates distinct papula
Conditions Studied
Interventions
- DEVICE Venus Viva
Study Locations (1)
California
- Laser and Skin Surgery Center of Northern California - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-08-19 |
| Est. Completion | 2020-03-03 |
| Phase | NA |
What the finished NCT04057768 record still lists
NCT04057768 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 120-participant average among 25 other Wrinkle trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Venus Viva is the first listed.
NCT04057768 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04057768 about?
NCT04057768 is a clinical study titled "Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles". The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.
What is the current status of trial NCT04057768?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-08-19. Estimated completion is 2020-03-03.
What conditions does trial NCT04057768 study?
This clinical trial studies the following conditions: Wrinkle, Acne Scars - Mixed Atrophic and Hypertrophic.
What interventions are being tested in trial NCT04057768?
The interventions under investigation include: Venus Viva (DEVICE).
Who is sponsoring clinical trial NCT04057768?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04057768 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04057768's enrollment target sits among peer trials
10 25th of 25 higher than 1 of 25 other Wrinkle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wrinkle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI